ICD-11 code 1C11.00 is used to classify Oroya fever, a bacterial infection caused by Bartonella bacilliformis. The disease is primarily found in South America, particularly in Peru, and is transmitted by the sand fly. Oroya fever is characterized by fever, anemia, and a weakened immune response.
The symptoms of Oroya fever can be severe, with patients experiencing high fevers, body aches, and headaches. In some cases, the infection can lead to complications such as liver and spleen enlargement, as well as skin lesions. Without prompt treatment, Oroya fever can be fatal.
Diagnosing Oroya fever typically involves a physical exam, blood tests, and possibly a biopsy of affected skin tissue. Treatment usually involves antibiotics, such as ciprofloxacin or doxycycline, to kill the bacteria. It is important for healthcare providers to be familiar with ICD-11 code 1C11.00 in order to accurately document cases of Oroya fever and track its prevalence.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
The equivalent SNOMED CT code for the ICD-11 code 1C11.00, which corresponds to Oroya fever, is 7695006. This particular SNOMED CT code specifically refers to the infectious disease caused by Bartonella bacilliformis, a bacterium transmitted by sandflies. Oroya fever is characterized by fever, anemia, and skin lesions, and is primarily found in South America, particularly in the Andes Mountains. By using SNOMED CT code 7695006, healthcare professionals can accurately document and track cases of Oroya fever in their patient populations. This coding system ensures consistency and accuracy in the classification and analysis of diseases, allowing for better monitoring and treatment of conditions like Oroya fever.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of Oroya fever, officially classified as 1C11.00 in the International Classification of Diseases, can vary in severity and presentation. The hallmark symptom of Oroya fever is fever, which can reach high temperatures. Patients may also experience severe anemia, with symptoms such as fatigue, weakness, and shortness of breath.
Other common symptoms of Oroya fever include headaches, muscle aches, and overall malaise. Some patients may develop a characteristic rash, which appears as small, raised red bumps on the skin. Additionally, individuals with Oroya fever may experience enlarged lymph nodes, particularly in the neck, armpits, or groin.
In severe cases, Oroya fever can lead to complications such as organ damage, including liver and spleen enlargement. Patients may also develop symptoms related to the destruction of red blood cells, such as jaundice. If left untreated, Oroya fever can be fatal due to these complications. Prompt diagnosis and treatment are essential to improve outcomes for individuals with Oroya fever.
🩺 Diagnosis
Diagnosis of Oroya fever, caused by the bacterium Bartonella bacilliformis, can be challenging due to its nonspecific symptoms. One common method of diagnosis is through the identification of the bacteria in blood smears using Giemsa, Wright, or Gimenez stains. This technique allows for the visualization of the characteristic coccobacilli within red blood cells.
Another diagnostic method for Oroya fever is through polymerase chain reaction (PCR) testing, which can detect Bartonella bacilliformis DNA in blood samples. PCR is a sensitive and specific tool for identifying the presence of the bacterium, particularly in cases where bacterial loads may be low or intermittent. This method is especially useful in confirming the diagnosis in patients with atypical symptoms or in regions where the disease is not commonly found.
In some cases, serologic testing may also be used to diagnose Oroya fever by detecting antibodies against Bartonella bacilliformis in the patient’s blood. Enzyme immunoassays (EIAs) and indirect fluorescent antibody (IFA) tests are commonly used serologic techniques for this purpose. However, serologic testing may not always be reliable, as cross-reactivity with other pathogens or previous exposure to Bartonella species can lead to false-positive results.
💊 Treatment & Recovery
Treatment for 1C11.00 (Oroya fever) typically involves a combination of antibiotics and supportive care. Antibiotics such as azithromycin, doxycycline, or chloramphenicol are commonly used to target the bacteria Bartonella bacilliformis, which causes Oroya fever.
Additionally, supportive care may include measures to manage symptoms such as fever, body aches, and fatigue. Patients may be given fluids to prevent dehydration, as well as pain relievers to alleviate discomfort. It is important for individuals with Oroya fever to seek medical treatment promptly to receive appropriate care and prevent complications.
Recovery from Oroya fever can vary depending on the severity of the infection and the individual’s overall health. In general, most patients with Oroya fever recover completely with proper treatment. However, some individuals may experience lingering symptoms or complications such as anemia.
Regular follow-up appointments with healthcare providers may be necessary to monitor progress and address any ongoing issues. Patients may also be advised to rest and take it easy while recovering from Oroya fever to allow their bodies time to fully heal. Overall, with appropriate medical care and rest, individuals with Oroya fever can expect to recover completely.
🌎 Prevalence & Risk
In the United States, 1C11.00, or Oroya fever, is an extremely rare disease. Only a handful of cases have been reported in the country, and most of these cases have been in individuals who have traveled to endemic regions in South America where the disease is more prevalent. Due to the rarity of the disease in the United States, awareness and understanding of Oroya fever among healthcare professionals is limited.
In Europe, cases of Oroya fever are also extremely rare. There have been a few reported cases in individuals who have traveled to endemic regions in South America, but overall, the disease is not considered a significant public health concern in Europe. As with the United States, awareness and understanding of Oroya fever among healthcare professionals in Europe is limited due to its rarity.
In Asia, Oroya fever is most commonly found in countries in South America, and cases in Asia are very rare. Due to the geographical distance between Asia and the endemic regions of Oroya fever, the prevalence of the disease in Asian countries is low. There have been a few reported cases in individuals who have traveled to endemic regions, but overall, Oroya fever is not considered a major public health concern in Asia.
In Africa, cases of Oroya fever are extremely rare. The disease is predominantly found in countries in South America, and cases in Africa are virtually non-existent. Due to the limited prevalence of Oroya fever in Africa, awareness and understanding of the disease among healthcare professionals is minimal.
😷 Prevention
To prevent Oroya fever (1C11.00), it is essential to take measures to avoid contracting the causative bacterium, Bartonella bacilliformis, which is transmitted through the bites of infected sand flies. One way to prevent the disease is to avoid outdoor activities during dusk and dawn when sand flies are most active. Using insect repellent containing DEET and wearing long-sleeved clothing can also help reduce the risk of being bitten by infected sand flies.
Additionally, travelers to regions where Oroya fever is endemic should take precautions such as sleeping in screened or air-conditioned rooms and using bed nets to prevent sand flies from entering living spaces. It is also advisable to treat clothing and gear with permethrin, an insecticide that can repel and kill sand flies. These preventive measures can greatly reduce the risk of contracting Oroya fever while traveling to areas where the disease is prevalent.
Furthermore, individuals living in or traveling to regions where Oroya fever is endemic should be aware of the symptoms of the disease, which include fever, body aches, and anemia. Seeking prompt medical attention if these symptoms develop can lead to early diagnosis and treatment, which can prevent serious complications associated with Oroya fever. Educating oneself about the disease and taking preventive measures can help reduce the risk of contracting Oroya fever and promote overall health and well-being.
🦠 Similar Diseases
One disease similar to 1C11.00 (Oroya fever) is Bartonellosis, also known as Carrion’s disease. This disease is caused by the bacterium Bartonella bacilliformis and is primarily found in South America, particularly in Peru, Ecuador, and Colombia. Similar to Oroya fever, Bartonellosis is characterized by fever, anemia, and hemolytic symptoms. The ICD-10 code for Bartonellosis is A44.9.
Another disease that shares similarities with Oroya fever is Rocky Mountain spotted fever, caused by the bacterium Rickettsia rickettsii. This disease is transmitted to humans through the bite of infected ticks and is commonly found in North and South America. Symptoms of Rocky Mountain spotted fever include fever, rash, headache, and muscle aches, resembling those of Oroya fever. The ICD-10 code for Rocky Mountain spotted fever is A77.1.
Lyme disease, caused by the bacterium Borrelia burgdorferi and transmitted through the bite of infected ticks, is another disease that can be compared to Oroya fever. Lyme disease is prevalent in North America, Europe, and Asia and is characterized by fever, fatigue, joint pain, and a distinctive rash called erythema migrans. Similar to Oroya fever, Lyme disease can lead to complications affecting multiple organ systems. The ICD-10 code for Lyme disease is A69.2.